Counterfeiting is a growing global problem. The infiltration of counterfeit drugs into mainstream supply chain in many countries poses a direct threat to consumer health, worldwide. The U.S. is no exception. Counterfeit products fall under the classification of intellectual property rights (IPR) violations. The U.S. Customs and Border Protection, reports that the domestic value of [...]
Filed under: Consumer Protection Alerts, FDA, FDA Guidance, Industry Guidance | Tagged: anti-counterfeiting, counterfeit drugs, FDA | 2 Comments »










